Le Lézard
Classified in: Health
Subject: CCA

Invitation to Essity's Q2 2018 Press Conference


STOCKHOLM, June 20, 2018 /PRNewswire/ -- The press conference held in connection with the publication of Essity's interim report for the second quarter of 2018 will also be available via webcast and it is possible to join by phone.

The interim report will be published on July 19, 2018 at approximately 07:00 CET. The subsequent press conference will be held at 09:00 CET at Essity's headquarters, Waterfront Building, Klarabergsviadukten 63, Stockholm, Sweden.

At the press conference, President and CEO Magnus Groth will present and answer questions regarding the report.

Press conference:

Date: Thursday, July 19, 2018
Time: 09:00 CET
Venue: Essity Headquarters, Waterfront Building, Klarabergsviadukten 63, Stockholm, Sweden

Link to webcast: https://essity.videosync.fi/2018-07-19-q2

The press conference will be webcast live at www.essity.com. It is also possible to participate in the press conference by telephone by calling +44 (0) 203-009-57-10, +1-866-869-23-21, or +46 (0)8-506-921-85. Call in good time before the conference starts. Provide the code "Essity" or the conference ID 5288956.

For further information, please contact:
Karl Stoltz
Media Relations Manager
+46-8-788-51-55
[email protected]

Johan Karlsson
Vice President Investor Relations
+46-8-788-51-30
[email protected]

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/essity/r/invitation-to-essity-s-q2-2018-press-conference,c2552892

The following files are available for download:

http://mb.cision.com/Main/15798/2552892/863178.pdf

Invitation to Essityâ?tms Q2 2018 press conference

SOURCE Essity


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: